Simon Nayler
Impact in
- Physiology top 2%
- Histiocytic Disorders and Treatments
- Oncology top 5%
- Viral-associated cancers and disorders
- Vascular Tumors and Angiosarcomas
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 8
- Vascular Tumors and Angiosarcomas 4
- Cancer Cells and Metastasis 3
-
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Christopher D.�M. Fletcher (4 shared papers)John K. C. Chan (2 shared papers)K Cooper (4 shared papers)Kum Cooper (2 shared papers)Kumarasen Cooper (3 shared papers)Brian P. Rubin (1 shared paper)Eduardo Calonje (1 shared paper)Gladwyn Leiman (2 shared papers)
- Journals
- Annals of Oncology (5 papers)Histopathology (3 papers)Molecular Pathology (2 papers)Cancer (2 papers)JCO Global Oncology (1 paper)
- Partner nations
- South AfricaUnited StatesFrance
In The Last Decade
Simon Nayler
38 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 70
- Physiology 701
- Oncology 648
- Pathology and Forensic Medicine 291
- Dermatology 109
- Rheumatology 147
Countries citing papers authored by Simon Nayler
This map shows the geographic impact of Simon Nayler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Nayler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Nayler more than expected).
Fields of papers citing papers by Simon Nayler
This network shows the impact of papers produced by Simon Nayler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Nayler. The network helps show where Simon Nayler may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Nayler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. | 1997 | 332 |
| 2 | 2015 | 260 | |
| 3 | 1997 | 234 | |
| 4 | 2000 | 83 | |
| 5 | 1996 | 50 | |
| 6 | 2002 | 48 | |
| 7 | 1997 | 42 | |
| 8 | 1998 | 42 | |
| 9 | 1996 | 32 | |
| 10 | 1998 | 30 | |
| 11 | Advanced prostate cancer with normal serum prostate-specific antigen values. | 1994 | 23 |
| 12 | 1997 | 21 | |
| 13 | 1995 | 21 | |
| 14 | 2019 | 19 | |
| 15 | 2022 | 18 | |
| 16 | 1998 | 18 | |
| 17 | 2014 | 12 | |
| 18 | 2022 | 11 | |
| 19 | 2014 | 11 | |
| 20 | 2023 | 10 |
About Simon Nayler
Simon Nayler is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Physiology, Cancer Research and Pathology and Forensic Medicine, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Histiocytic Disorders and Treatments (8 papers), Breast Cancer Treatment Studies (5 papers), Immunotherapy and Immune Responses (4 papers), Vascular Tumors and Angiosarcomas (4 papers), Cancer Cells and Metastasis (3 papers), Soft tissue tumor case studies (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Physiology (701 citations), Oncology (648 citations), Pathology and Forensic Medicine (291 citations), Dermatology (109 citations) and Rheumatology (147 citations). Simon Nayler has collaborated with scholars based in South Africa, United States and France. Frequent co-authors include Christopher D.�M. Fletcher, John K. C. Chan, K Cooper, Kum Cooper, John K. C. Chan, Kumarasen Cooper, Brian P. Rubin, Eduardo Calonje, Gladwyn Leiman and Petra Windmolders. Their work appears in journals such as Annals of Oncology, Histopathology, Molecular Pathology, Cancer and JCO Global Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.